Citi analyst Mohit Bansal upgraded Regeneron Pharma (NASDAQ: REGN) from Neutral to Buy with a price target of $420.00 (from ...

(Premium-only article. Please sign in or upgrade to SI Premium to view.)

Analyst Comments Analyst PT Change Hot Comments Hot Upgrades Upgrades